Sara Hurvitz: search on Z-Library

The world's largest scientific articles store. 70,000,000+ articles for free.

Don't use scam websites

1

The Genus of a Map

Journal:

Transactions of the American Mathematical Society

Year:

1981

Language:

english

File:

PDF, 2.16 MB

english, 1981

2

Antibody-Drug Conjugates (Fundamentals, Drug Development, and Clinical Outcomes to Target Cancer) || Pharmacokinetics of Antibody-Drug Conjugates

Olivier, Kenneth J., Hurvitz, Sara A.

Year:

2016

Language:

english

File:

PDF, 187 KB

english, 2016

3

Antibody-Drug Conjugates (Fundamentals, Drug Development, and Clinical Outcomes to Target Cancer) || Linker and Conjugation Technology; and Improvements

Olivier, Kenneth J., Hurvitz, Sara A.

Year:

2016

Language:

english

File:

PDF, 133 KB

english, 2016

4

Antibody-Drug Conjugates (Fundamentals, Drug Development, and Clinical Outcomes to Target Cancer) || Occupational Health and Safety Aspects of ADCs and Their Toxic Payloads

Olivier, Kenneth J., Hurvitz, Sara A.

Year:

2016

Language:

english

File:

PDF, 555 KB

english, 2016

5

Antibody-Drug Conjugates (Fundamentals, Drug Development, and Clinical Outcomes to Target Cancer) || Antibody-Drug Conjugates (ADCs) in Clinical Development

Olivier, Kenneth J., Hurvitz, Sara A.

Year:

2016

Language:

english

File:

PDF, 200 KB

english, 2016

6

Antibody-Drug Conjugates (Fundamentals, Drug Development, and Clinical Outcomes to Target Cancer) || Antibody-Drug Conjugates: An Overview of the CMC and Characterization Process

Olivier, Kenneth J., Hurvitz, Sara A.

Year:

2016

Language:

english

File:

PDF, 219 KB

english, 2016

7

Preclinical activity of abemaciclib alone or in combination with anti-mitotic and targeted therapies in breast cancer

O'Brien, Neil, Conklin, Dylan, Beckmann, Richard, Luo, Tong, Chau, Kevin, Thomas, Josh, Mc Nulty, Ann, Marchal, Christophe, Kalous, Ondrej, von Euw, Erika, Hurvitz, Sara, Mockbee, Colleen, Slamon, Den

Journal:

Molecular Cancer Therapeutics

Year:

2018

Language:

english

File:

PDF, 5.67 MB

english, 2018

8

Ribociclib plus endocrine therapy for premenopausal women with hormone-receptor-positive, advanced breast cancer (MONALEESA-7): a randomised phase 3 trial

Tripathy, Debu, Im, Seock-Ah, Colleoni, Marco, Franke, Fabio, Bardia, Aditya, Harbeck, Nadia, Hurvitz, Sara A, Chow, Louis, Sohn, Joohyuk, Lee, Keun Seok, Campos-Gomez, Saul, Villanueva Vazquez, Rafae

Journal:

The Lancet Oncology

Year:

2018

Language:

english

File:

PDF, 430 KB

english, 2018

9

Rational management of endocrine resistance in breast cancer : A comprehensive review of estrogen receptor biology, treatment options, and future directions

Sara A. Hurvitz, Richard J. Pietras

Journal:

Year:

2008

Language:

english

File:

PDF, 277 KB

english, 2008

10

A Phase II Trial of Docetaxel With Bevacizumab as First-line Therapy for HER2-Negative Metastatic Breast Cancer (TORI B01)

Sara A. Hurvitz, Heather J. Allen, Rebecca L. Moroose, David Chan, Christopher Hagenstad, Steven H. Applebaum, Giribala Patel, Eddie H. Hu, Nancy Ryba, Lii-Shin Lin, HeJing Wang, John Glaspy, Dennis J

Journal:

Clinical Breast Cancer

Year:

2010

Language:

english

File:

PDF, 598 KB

english, 2010

11

Evolving options for the treatment of metastatic breast cancer: Progression-free survival as an endpoint

Sara A. Hurvitz

Journal:

Cancer Treatment Reviews

Year:

2011

Language:

english

File:

PDF, 207 KB

english, 2011

12

Current approaches and future directions in the treatment of HER2-positive breast cancer

Hurvitz, Sara A., Hu, Yufang, O’Brien, Neil, Finn, Richard S.

Journal:

Cancer Treatment Reviews

Year:

2013

Language:

english

File:

PDF, 397 KB

english, 2013

13

A phase 2 study of everolimus combined with trastuzumab and paclitaxel in patients with HER2-overexpressing advanced breast cancer that progressed during prior trastuzumab and taxane therapy

Hurvitz, Sara A., Dalenc, Florence, Campone, Mario, OâRegan, Ruth M., Tjan-Heijnen, Vivianne C., Gligorov, Joseph, Llombart, Antonio, Jhangiani, Haresh, Mirshahidi, Hamid R., Tan-Chiu, Elizabeth, Mi

Journal:

Breast Cancer Research and Treatment

Year:

2013

Language:

english

File:

PDF, 327 KB

english, 2013

14

PI3K pathway inhibitors for the treatment of brain metastases with a focus on HER2+ breast cancer

Peddi, Parvin F., Hurvitz, Sara A.

Journal:

Journal of Neuro-Oncology

Year:

2014

Language:

english

File:

PDF, 502 KB

english, 2014

15

Use of the metastatic breast cancer progression (MBC-P) questionnaire to assess the value of progression-free survival for women with metastatic breast cancer

Hurvitz, Sara A., Lalla, Deepa, Crosby, Ross D., Mathias, Susan D.

Journal:

Breast Cancer Research and Treatment

Year:

2013

Language:

english

File:

PDF, 187 KB

english, 2013

16

nab-Paclitaxel in combination with biologically targeted agents for early and metastatic breast cancer

Megerdichian, Christine, Olimpiadi, Yuliya, Hurvitz, Sara A.

Journal:

Cancer Treatment Reviews

Year:

2014

Language:

english

File:

PDF, 350 KB

english, 2014

17

PO59 EFFICACY AND SAFETY OF EVEROLIMUS PLUS EXEMESTANE COMBINATION THERAPY VERSUS MONOTHERAPY WITH EVEROLIMUS OR CAPECITABINE IN HR+, HER2− BREAST CANCER: A MULTI-CENTER, OPEN-LABEL, PHASE 2 TRIAL BOLERO-6

de Boer, Richard, Jerusalem, Guy, Hurvitz, Sara, Ejlertsen, Bent, El-Hashimy, Mona, Feng, Wentao, Taran, Tetiana, Burris, Howard

Journal:

Year:

2013

Language:

english

File:

PDF, 53 KB

english, 2013

18

Noninfectious pneumonitis with the use of mTOR inhibitors in breast cancer

Peddi, Parvin F., Shatsky, Rebecca A., Hurvitz, Sara A.

Journal:

Cancer Treatment Reviews

Year:

2014

Language:

english

File:

PDF, 635 KB

english, 2014

19

The SystHERs registry: an observational cohort study of treatment patterns and outcomes in patients with human epidermal growth factor receptor 2–positive metastatic breast cancer

Tripathy, Debu, Rugo, Hope S, Kaufman, Peter A, Swain, Sandra, O’Shaughnessy, Joyce, Jahanzeb, Mohammad, Mason, Ginny, Beattie, Mary, Yoo, Bongin, Lai, Catherine, Masaquel, Anthony, Hurvitz, Sara

Journal:

Year:

2014

Language:

english

File:

PDF, 345 KB

english, 2014

20

Identification and cost of adverse events in metastatic breast cancer in taxane and capecitabine based regimens

Hansen, Ryan N, Ramsey, Scott D, Lalla, Deepa, Masaquel, Anthony, Kamath, Tripthi, Brammer, Melissa, Hurvitz, Sara A, Sullivan, Sean D

Journal:

Year:

2014

Language:

english

File:

PDF, 451 KB

english, 2014

21

Cardiac safety results from a phase II, open-label, multicenter, pilot study of two docetaxel-based regimens plus bevacizumab for the adjuvant treatment of subjects with node-positive or high-risk node-negative breast cancer

Hurvitz, Sara A, Bosserman, Linda D, Chan, David, Hagenstad, Christopher T, Kass, Frederick C, Smith, Frederick P, Rodriguez, Gladys I, Childs, Barrett H, Slamon, Dennis J

Journal:

Year:

2014

Language:

english

File:

PDF, 225 KB

english, 2014

22

Afatinib in the treatment of breast cancer

Hurvitz, Sara A, Shatsky, Rebecca, Harbeck, Nadia

Journal:

Expert Opinion on Investigational Drugs

Year:

2014

Language:

english

File:

PDF, 275 KB

english, 2014

23

Antibody-drug conjugates: an emerging modality for the treatment of cancer

Leal, Mauricio, Sapra, Puja, Hurvitz, Sara A., Senter, Peter, Wahl, Alan, Schutten, Melissa, Shah, Dhaval K., Haddish-Berhane, Nahor, Kabbarah, Omar

Journal:

Annals of the New York Academy of Sciences

Year:

2014

Language:

english

File:

PDF, 597 KB

english, 2014

24

Recombinant, tumour-derived idiotype vaccination for indolent B cell non-Hodgkin’s lymphomas: a focus on FavId™

Hurvitz, Sara A, Timmerman, John M

Journal:

Expert Opinion on Biological Therapy

Year:

2005

Language:

english

File:

PDF, 603 KB

english, 2005

25

Patient-reported outcomes from EMILIA, a randomized phase 3 study of trastuzumab emtansine (T-DM1) versus capecitabine and lapatinib in human epidermal growth factor receptor 2-positive locally advanced or metastatic breast cancer

Welslau, Manfred, Diéras, Veronique, Sohn, Joo-Hyuk, Hurvitz, Sara A., Lalla, Deepa, Fang, Liang, Althaus, Betsy, Guardino, Ellie, Miles, David

Journal:

Year:

2014

Language:

english

File:

PDF, 575 KB

english, 2014

26

Trastuzumab emtansine: the first targeted chemotherapy for treatment of breast cancer

Peddi, Parvin F, Hurvitz, Sara A

Journal:

Future Oncology

Year:

2013

Language:

english

File:

PDF, 829 KB

english, 2013

27

In vitro activity of the mTOR inhibitor everolimus, in a large panel of breast cancer cell lines and analysis for predictors of response

Hurvitz, Sara A., Kalous, Ondrej, Conklin, Dylan, Desai, Amrita J., Dering, Judy, Anderson, Lee, O’Brien, Neil A., Kolarova, Teodora, Finn, Richard S., Linnartz, Ronald, Chen, David, Slamon, Dennis J.

Journal:

Breast Cancer Research and Treatment

Year:

2015

Language:

english

File:

PDF, 708 KB

english, 2015

28

Trebananib (AMG 386) plus weekly paclitaxel with or without bevacizumab as first-line therapy for HER2-negative locally recurrent or metastatic breast cancer: A phase 2 randomized study

Diéras, Véronique, Wildiers, Hans, Jassem, Jacek, Dirix, Luc Y., Guastalla, Jean-Paul, Bono, Petri, Hurvitz, Sara A., Gonçalves, Anthony, Romieu, Gilles, Limentani, Steven A., Jerusalem, Guy, Lakshmai

Journal:

Year:

2015

Language:

english

File:

PDF, 1.06 MB

english, 2015

29

Relationship between HER2 expression and efficacy with first-line trastuzumab emtansine compared with trastuzumab plus docetaxel in TDM4450g: a randomized phase II study of patients with previously untreated HER2-positive metastatic breast cancer

Perez, Edith A, Hurvitz, Sara A, Amler, Lukas C, Mundt, Kirsten E, Ng, Vivian, Guardino, Ellie, Gianni, Luca

Journal:

Breast Cancer Research

Year:

2014

Language:

english

File:

PDF, 409 KB

english, 2014

30

Symptom Burden and Quality of Life among Women with HER2 + Metastatic Breast Cancer

Mayer, Musa, Lang, Kathleen, Hurvitz, Sara, Lalla, Deepa, Federico, Victoria, Brammer, Melissa, Menzin, Joseph, Tripathy, Debu

Journal:

The Breast Journal

Year:

2015

Language:

english

File:

PDF, 119 KB

english, 2015

31

Combination of everolimus with trastuzumab plus paclitaxel as first-line treatment for patients with HER2-positive advanced breast cancer (BOLERO-1): a phase 3, randomised, double-blind, multicentre trial

Hurvitz, Sara A, Andre, Fabrice, Jiang, Zefei, Shao, Zhimin, Mano, Max S, Neciosup, Silvia P, Tseng, Ling-Min, Zhang, Qingyuan, Shen, Kunwei, Liu, Donggeng, Dreosti, Lydia M, Burris, Howard A, Toi, Ma

Journal:

The Lancet Oncology

Year:

2015

Language:

english

File:

PDF, 422 KB

english, 2015

32

What’s positive about ‘triple-negative’ breast cancer?

Hurvitz, Sara A, Finn, Richard S

Journal:

Future Oncology

Year:

2009

Language:

english

File:

PDF, 511 KB

english, 2009

33

Afatinib alone or afatinib plus vinorelbine versus investigator's choice of treatment for HER2-positive breast cancer with progressive brain metastases after trastuzumab, lapatinib, or both (LUX-Breast 3): a randomised, open-label, multicentre, phase 2 trial

Cortés, Javier, Dieras, Véronique, Ro, Jungsil, Barriere, Jérôme, Bachelot, Thomas, Hurvitz, Sara, Le Rhun, Emilie, Espié, Marc, Kim, Sung-Bae, Schneeweiss, Andreas, Sohn, Joo Hyuk, Nabholtz, Jean-Mar

Journal:

The Lancet Oncology

Year:

2015

Language:

english

File:

PDF, 384 KB

english, 2015

34

Afatinib plus vinorelbine versus trastuzumab plus vinorelbine in patients with HER2-overexpressing metastatic breast cancer who had progressed on one previous trastuzumab treatment (LUX-Breast 1): an open-label, randomised, phase 3 trial

Harbeck, Nadia, Huang, Chiun-Sheng, Hurvitz, Sara, Yeh, Dah-Cherng, Shao, Zhimin, Im, Seock-Ah, Jung, Kyung Hae, Shen, Kunwei, Ro, Jungsil, Jassem, Jacek, Zhang, Qingyuan, Im, Young-Hyuck, Wojtukiewic

Journal:

The Lancet Oncology

Year:

2016

Language:

english

File:

PDF, 575 KB

english, 2016

35

Successful Treatment With Cyclophosphamide of Life-threatening Diffuse Hemangiomatosis Involving the Liver

Hurvitz, Sara A., Hurvitz, Carole H., Sloninsky, Liliana, Sanford, Margaret C.

Journal:

Journal of Pediatric Hematology/Oncology

Year:

2000

Language:

english

File:

PDF, 453 KB

english, 2000

36

NatHER: protocol for systematic evaluation of trends in survival among patients with HER2-positive advanced breast cancer

Korner, Eli J., Morris, Anne, Allen, Isabel Elaine, Hurvitz, Sara, Beattie, Mary S., Kalesan, Bindu

Journal:

Systematic Reviews

Year:

2015

Language:

english

File:

PDF, 423 KB

english, 2015

37

HERMIONE: a randomized Phase 2 trial of MM-302 plus trastuzumab versus chemotherapy of physician’s choice plus trastuzumab in patients with previously treated, anthracycline-naïve, HER2-positive, locally advanced/metastatic breast cancer

Miller, Kathy, Cortes, Javier, Hurvitz, Sara A., Krop, Ian E., Tripathy, Debu, Verma, Sunil, Riahi, Kaveh, Reynolds, Joseph G., Wickham, Thomas J., Molnar, Istvan, Yardley, Denise A.

Journal:

Year:

2016

Language:

english

File:

PDF, 1.47 MB

english, 2016

38

New directions in the neoadjuvant treatment of HER2+ breast cancer

Hobbs, Evthokia A, Hurvitz, Sara A

Journal:

Breast Cancer Management

Year:

2015

Language:

english

File:

PDF, 904 KB

english, 2015

39

Triple-negative breast cancer

Hurvitz, Sara, Mead, Monica

Journal:

Current Opinion in Obstetrics & Gynecology

Year:

2015

Language:

english

File:

PDF, 259 KB

english, 2015

40

How I Treat Patients with HER2-Positive Metastatic Breast Cancer

Journal:

Year:

2014

Language:

english

File:

PDF, 143 KB

english, 2014

41

Human epidermal growth factor receptor-2-positive breast cancer: current management of early, advanced, and recurrent disease

Callahan, Rena, Hurvitz, Sara

Journal:

Current Opinion in Obstetrics & Gynecology

Year:

2011

Language:

english

File:

PDF, 335 KB

english, 2011

42

Current status of therapeutic vaccines for non-Hodgkin??s lymphoma

Hurvitz, Sara A, Timmerman, John M

Journal:

Current Opinion in Oncology

Year:

2005

Language:

english

File:

PDF, 114 KB

english, 2005

43

Combination of Cyclophosphamide, Rituximab, and Intratumoral CpG Oligodeoxynucleotide Successfully Eradicates Established B cell Lymphoma

Betting, David J., Hurvitz, Sara A., Steward, Kristopher K., Yamada, Reiko E., Kafi, Kamran, van Rooijen, Nico, Timmerman, John M.

Journal:

Journla of Immunotherapy

Year:

2012

Language:

english

File:

PDF, 661 KB

english, 2012

44

Increasing AppropriateBRCA1/2Mutation Testing: The Role of Family History Documentation and Genetic Counseling in a Multidisciplinary Clinic

Kishan, Amar U., Gomez, Caitlin L., Dawson, Nicole A., Dvorak, Robyn, Foster, Nova M., Hoyt, Anne, Hurvitz, Sara A., Kusske, Amy, Silver, Erica L., Tseng, Charles, McCloskey, Susan A.

Journal:

Annals of Surgical Oncology

Year:

2016

Language:

english

File:

PDF, 481 KB

english, 2016

45

Antibody-Drug Conjugates (Fundamentals, Drug Development, and Clinical Outcomes to Target Cancer) || Radioimmunotherapy

Olivier, Kenneth J., Hurvitz, Sara A.

Year:

2016

Language:

english

File:

PDF, 152 KB

english, 2016

46

Antibody-Drug Conjugates (Fundamentals, Drug Development, and Clinical Outcomes to Target Cancer) || Formulation and Stability

Olivier, Kenneth J., Hurvitz, Sara A.

Year:

2016

Language:

english

File:

PDF, 266 KB

english, 2016

47

Antibody-Drug Conjugates (Fundamentals, Drug Development, and Clinical Outcomes to Target Cancer) || Typical Antibody-Drug Conjugates

Olivier, Kenneth J., Hurvitz, Sara A.

Year:

2016

Language:

english

File:

PDF, 677 KB

english, 2016

48

Antibody-Drug Conjugates (Fundamentals, Drug Development, and Clinical Outcomes to Target Cancer) || ADCs Approved for Use: Brentuximab Vedotin

Olivier, Kenneth J., Hurvitz, Sara A.

Year:

2016

Language:

english

File:

PDF, 238 KB

english, 2016

49

Antibody-Drug Conjugates (Fundamentals, Drug Development, and Clinical Outcomes to Target Cancer) || Selecting Optimal Antibody-Drug Conjugate Targets Using Indication-Dependent or Indication-Independent Approaches

Olivier, Kenneth J., Hurvitz, Sara A.

Year:

2016

Language:

english

File:

PDF, 908 KB

english, 2016

50

Antibody-Drug Conjugates (Fundamentals, Drug Development, and Clinical Outcomes to Target Cancer) || Antibody-Drug Conjugates: Clinical Strategies and Applications

Olivier, Kenneth J., Hurvitz, Sara A.

Year:

2016

Language:

english

File:

PDF, 234 KB

english, 2016